- Latest available (Revised)
- Original (As adopted by EU)
Council regulation (EC) No 467/97Show full title
Council regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished Pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical
You are here:
- Regulations originating from the EU
- 1997 No. 467
- Whole Regulation
- Previous
- Next
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
This item of legislation originated from the EU
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Changes over time for: Council regulation (EC) No 467/97
Changes to legislation:
This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Council regulation (EC) No 467/97
of 3 March 1997
providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished Pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Community, and in particular Article 113 thereof,
Having regard to the proposal from the Commission,
Whereas, in the course of the Uruguay Round negotiations the Community and a number of countries discussed duty-free treatment of pharmaceutical products;
Whereas the participants in those discussions concluded that in addition to products falling within the Harmonized System (HS) Chapter 30 and HS headings 2936, 2937, 2939 and 2941, duty-free treatment should be given to designated pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization as well as specified salts, esters and hydrates of such INNs, and also to designated products used for the production and manufacture of finished products;
Whereas the results of the discussions, as set out in the record of discussions, were incorporated into the tariff schedules of the participants annexed to the Marrakesh Protocol to GATT 1994;
Whereas they also concluded that representatives of the WTO members party to the record of discussions would meet under the auspices of the Council for Trade in Goods of the WTO, normally at least once every three years — to review the product coverage with a view to including, by consensus, additional pharmaceutical products for tariff elimination;
Whereas the first such review has taken place with the conclusion that a certain number of additional INNs and products used for production and manufacture of finished Pharmaceuticals should be granted duty-free treatment and that the list of specified prefixes and suffixes for salts and esters of INNs should be expanded;
Whereas in the context of the review it was concluded that it was appropriate to rectify the situation with regard to certain INNs whose use was predominantly non-pharmaceutical and which had been inadvertently included among those INNs already receiving duty-free treatment,
HAS ADOPTED THIS REGULATION:
Article 1U.K.
From 1 April 1997 the Community shall also accord duty-free treatment for the INNs listed in Annex I as well as the salts, esters and hydrates of such products.
Article 2U.K.
From 1 April 1997 the Community shall also grant duty-free treatment for the products used in the production and manufacture of pharmaceutical products listed in Annex II.
Article 3U.K.
From 1 April 1997 the specified prefixes and suffixes of INNs eligible for duty-free treatment shall also include those listed in Annex III.
Article 4U.K.
From 1 April 1997 the products listed in Annex IV together with the salts, esters and hydrates of such products shall no longer benefit from duty-free treatment.
Article 5U.K.
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Communities.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 3 March 1997.
For the Council
The President
M. de Boer
ANNEX IU.K.Additional INNs to receive duty-free treatment
| CN code | CAS RN | Name |
|---|---|---|
| 2844 40 30 | 113716-48-6 | Iolopride (123 I) |
| 142481-95-6 | Technetium (99m Tc) furifosmin | |
| 2846 90 00 | 131069-91-5 | Gadoversetamide |
| 135326-11-3 | Gadoxetic acid | |
| 138721-73-0 | Sprodiamide | |
| 2914 40 90 | 20098-14-0 | Idramantone |
| 2916 39 00 | 71109-09-6 | Vedaprofen |
| 2918 30 00 | 22161-81-5 | Dexketoprofen |
| 112665-43-7 | Seratrodast | |
| 2918 90 90 | 139403-31-9 | Pimilprost |
| 2921 49 90 | 136236-51-6 | Rasagiline |
| 2922 49 70 | 6582-31-6 | Dapabutan |
| 2923 90 00 | 1794-75-8 | Laurcetium bromide |
| 2924 10 00 | 1675-66-7 | Adelmidrol |
| 62304-98-7 | Thymalfasin | |
| 132787-19-0 | Tradecamide | |
| 129009-83-2 | Versetamide | |
| 2924 29 90 | 147362-57-0 | Loviride |
| 94497-51-5 | Tamibarotene | |
| 2925 19 80 | 144849-63-8 | Bisnafide |
| 2925 20 00 | 137159-92-3 | Aptiganel |
| 2926 90 80 | 137109-71-8 | Balazipone |
| 147076-36-6 | Laflunimus | |
| 2928 00 90 | 141579-54-6 | Fenleuton |
| 2930 90 16 | 87573-01-1 | Salnacedin |
| 2930 90 70 | 90357-06-5 | Bicalutamide |
| 112573-72-5 | Dexecadotril | |
| 107023-41-6 | Pobilukast | |
| 81110-73-8 | Racecadotril | |
| 2931 00 50 | 132236-18-1 | Zifrosilone |
| 2931 00 80 | 114084-78-5 | Ibandronic acid |
| 124351-85-5 | Incadronic acid | |
| 63132-39-8 | Olpadronic acid | |
| 2932 99 70 | 105674-77-9 | Lanproston |
| 2932 99 90 | 123407-36-3 | Arteflene |
| 132017-01-7 | Bervastatin | |
| 110816-79-0 | Cromoglicate lisetil | |
| 149494-37-1 | Ebalzotan | |
| 151581-24-7 | Iralukast | |
| 113806-05-6 | Olopatadine | |
| 139110-80-8 | Zanamivir | |
| 2933 29 90 | 158682-68-9 | Elisartan |
| 116684-92-5 | Galdansetron | |
| 89371-44-8 | Imidaprilat | |
| 138402-11-6 | Irbesartan | |
| 118072-93-8 | Zoledronic acid | |
| 2933 39 95 | 119257-34-0 | Besipirdine |
| 118248-91-2 | Fodipir | |
| 155415-08-0 | Inogatran | |
| 121750-57-0 | Itameline | |
| 144412-49-7 | Lamifiban | |
| 155319-91-8 | Mangafodipir | |
| 150443-71-3 | Nicanartine | |
| 29876-14-0 | Nicotredole | |
| 144035-83-6 | Piclamilast | |
| 137795-35-8 | Spiroglumide | |
| 147025-53-4 | Talsaclidine | |
| 149488-17-5 | Trovirdine | |
| 2933 40 10 | 127294-70-6 | Balofloxacin |
| 143383-65-7 | Premafloxacin | |
| 143224-34-4 | Telinavir | |
| 2933 40 90 | 96946-42-8 | Cisatracurium besilate |
| 158966-92-8 | Montelukast | |
| 136668-42-3 | Quiflapon | |
| 2933 59 70 | 127266-56-2 | Adatanserin |
| 106941-25-7 | Adefovir | |
| 113852-37-2 | Cidofovir | |
| 150756-35-7 | Efletirizine | |
| 119687-33-1 | Iganidipine | |
| 127759-89-1 | Lobucavir | |
| 140945-32-0 | Mapinastine | |
| 134208-17-6 | Mazapertine | |
| 96604-21-6 | Ocinaplon | |
| 148504-51-2 | Ripisartan | |
| 115762-17-9 | Ruzadolane | |
| 118420-47-6 | Tagorizine | |
| 137234-62-9 | Voriconazole | |
| 151319-34-5 | Zaleplon | |
| 2933 79 00 | 148396-36-5 | Fradafiban |
| 74436-00-3 | Geclosporin | |
| 143943-73-1 | Lirequinil | |
| 106730-54-5 | Olprinone | |
| 135548-15-1 | Oxeclosporin | |
| 145733-36-4 | Tasosartan | |
| 143343-83-3 | Toborinone | |
| 2933 90 95 | 137882-98-5 | Abitesartan |
| 114607-46-4 | Acitazanolast | |
| 120511-73-1 | Anastrozole | |
| 134523-00-5 | Atorvastatin | |
| 128270-60-0 | Bivalirudin | |
| 139481-59-7 | Candesartan | |
| 54278-85-2 | Candocuronium iodide | |
| 105806-65-3 | Efegatran | |
| 62568-57-4 | Emideltide | |
| 120081-14-3 | Goralatide | |
| 142880-36-2 | Ilornastat | |
| 62732-44-9 | Ipidacrine | |
| 116287-14-0 | Lanperisone | |
| 112809-51-5 | Letrozole | |
| 116644-53-2 | Mibefradil | |
| 136122-46-8 | Mipitroban | |
| 144702-17-0 | Pomisartan | |
| 132036-88-5 | Ramosetron | |
| 106308-44-5 | Rufinamide | |
| 144701-48-4 | Telmisartan | |
| 147059-72-1 | Trovafloxacin | |
| 2934 10 00 | 149079-51-6 | Cartasteine |
| 128312-51-6 | Cinalukast | |
| 51287-57-1 | Denotivir | |
| 101001-34-7 | Pamicogrel | |
| 136433-51-7 | Tazofelone | |
| 138742-43-5 | Zankiren | |
| 2934 20 90 | 144665-07-6 | Lubeluzole |
| 150915-41-6 | Perospirone | |
| 146939-27-7 | Ziprasidone | |
| 2934 90 60 | 130370-60-4 | Batimastat |
| 133040-01-4 | Eprosartan | |
| 135202-79-8 | Ilonidap | |
| 114686-12-3 | Imitrodast | |
| 132418-36-1 | Rocepafant | |
| 132418-35-0 | Setipafant | |
| 2934 90 70 | 125533-88-2 | Mofarotene |
| 127045-41-4 | Pazufloxacin | |
| 2934 90 80 | 118292-40-3 | Tazarotene |
| 2934 90 98 | 151356-08-0 | Afovirsen |
| 138298-79-0 | Alnespirone | |
| 152317-89-0 | Alniditan | |
| 153420-96-3 | Atibeprone | |
| 143393-27-5 | Azalanstat | |
| 149908-53-2 | Azimilide | |
| 150490-85-0 | Berupipam | |
| 154361-50-9 | Capecitabine | |
| 133099-04-4 | Darifenacin | |
| 137500-42-6 | Darsidomine | |
| 114030-44-3 | Dexpemedolac | |
| 115464-77-2 | Elopiprazole | |
| 141790-23-0 | Fozivudine tidoxil | |
| 122254-45-9 | Glenvastatin | |
| 143443-90-7 | Ifetroban | |
| 82857-82-7 | Ilepcimide | |
| 104454-71-9 | Ipenoxazone | |
| 118288-08-7 | Lafutidine | |
| 138068-37-8 | Lepirudin | |
| 78994-23-7 | Levormeloxifene | |
| 116476-16-5 | Levosemotiadil | |
| 148152-63-0 | Napitane | |
| 84558-93-0 | Netivudine | |
| 147432-77-7 | Ontazolast | |
| 139225-22-2 | Panamesine | |
| 103255-66-9 | Pazinaclone | |
| 123447-62-1 | Prulifloxacin | |
| 131986-45-3 | Xanomeline | |
| 145781-32-4 | Zolasartan | |
| 2935 00 90 | 147536-97-8 | Bosentan |
| 136817-59-9 | Delavirdine | |
| 119905-05-4 | Delequamine | |
| 112966-96-8 | Domitroban | |
| 125279-79-0 | Ersentilide | |
| 139133-26-9 | Lexipafant | |
| 154397-77-0 | Napsagatran | |
| 139133-27-0 | Nupafant | |
| 116649-85-5 | Ramatroban | |
| 133276-80-9 | Samixogrel | |
| 146623-69-0 | Saprisartan | |
| 149556-49-0 | Susalimod | |
| 144494-65-5 | Tirofiban | |
| 139308-65-9 | Tolafentrine | |
| 107753-78-6 | Zafirlukast | |
| 2936 29 90 | 131875-08-6 | Lexacalcitol |
| 2937 10 10 | 9002-68-0 | Follitropin alfa |
| 152923-57-4 | Lutropin alfa | |
| 2937 22 00 | 103466-73-5 | Icometasone enbutate |
| 2937 29 90 | 144459-70-1 | Rofleponide |
| 2937 99 00 | 124478-60-0 | Aglepristone |
| 140703-51-1 | Examorelin | |
| 133107-64-9 | Insulin lispro | |
| 144743-92-0 | Teverelix | |
| 2939 50 90 | 151581-23-6 | Apaxifylline |
| 132210-43-6 | Cipamfylline | |
| 100324-81-0 | Lisofylline | |
| 98833-92-2 | Stacofylline | |
| 2939 90 90 | 135905-89-4 | Mirisetron |
| 117086-68-7 | Ricasetron | |
| 25775-90-0 | Zucapsaicin | |
| 2940 00 90 | 133692-55-4 | Seprilose |
| 2941 90 00 | 127785-64-2 | Basifungin |
| 116853-25-9 | Cefluprenam | |
| 122841-10-5 | Cefoselis | |
| 156131-91-8 | Dimadectin | |
| 123997-26-2 | Eprinomectin | |
| 149951-16-6 | Lenapenem | |
| 108852-90-0 | Nemorubicin | |
| 159445-62-2 | Orientiparcin | |
| 156769-21-0 | Sanfetrinem | |
| 3001 90 99 | 120993-53-5 | Desirudin |
| 3002 10 91 | 143653-53-6 | Abciximab |
| 156227-98-4 | Afelimomab | |
| 151763-64-3 | Capromab | |
| 152923-56-3 | Dacliximab | |
| 145832-33-3 | Detumomab | |
| 142864-19-5 | Enlimomab | |
| 152981-31-2 | Inolimomab | |
| 150631-27-9 | Nacolomab tafenatox | |
| 159445-64-4 | Odulimomab | |
| 147191-91-1 | Priliximab | |
| 153101-26-9 | Regavirumab | |
| 148189-70-2 | Votumumab | |
| 3002 10 95 | 143090-92-0 | Anakinra |
| 143631-61-2 | Atexakin alfa | |
| 148637-05-2 | Cilmostim | |
| 154725-65-2 | Epoetin epsilon | |
| 148363-16-0 | Epoetin omega | |
| 102786-52-7 | Eptacog alfa (activated) | |
| 156679-34-4 | Lenercept | |
| 124146-64-1 | Mobenakin | |
| 0-00-0 | Moroctocog alfa | |
| 148641-02-5 | Muplestim | |
| 139076-62-3 | Octocog alfa | |
| 3003 39 00 | 0-00-0 | Plusonermin |
| 3003 90 90 | 0-00-0 | Fuladectin |
| 3507 90 90 | 143831-71-4 | Dornase alfa |
| 154248-97-2 | Imiglucerase | |
| 149394-67-2 | Ledimase | |
| 156616-23-8 | Monteplase | |
| 159445-63-3 | Nateplase | |
| 155773-57-2 | Pegorgotein | |
| 3911 90 19 | 95522-45-5 | Colestilan |
| 31512-74-0 | Polixetonium chloride | |
| 3913 90 80 | 39464-87-4 | Betasizofiran |
| 0-00-0 | Certoparin sodium | |
| 0-00-0 | Minolteparin sodium |
ANNEX IIU.K.Additional pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to receive duty-free treatment
| CN code | CAS RN | Name |
|---|---|---|
| 2843 30 00 | 12192-57-3 | (alpha-D-glucopyranosylthio) gold |
| 2903 69 90 | 42074-68-0 | 1-chloro-2-(chlorodiphenylmethyl) benzene |
| 76283-09-5 | alpha,4-dibromo-2-fluorotoluene | |
| 2906 29 90 | 104265-58-9 | 2-[(1 S,2R)-6-fluoro-2-hydroxy-1 -isopropyl-1,2,3,4-tetrahydro-2-naphthyl] ethyl p-toluenesulfonate |
| 2907 29 90 | 700-13-0 | 2,3,5-tximethylhydroquinone |
| 2909 50 90 | 63659-16-5 | 4-[2-(cyclopropylmethoxy) ethyl] phenol |
| 2914 40 90 | 80-75-1 | 11-alpha-hydroxypregn-4-ene-3,20-dione |
| 2914 50 00 | 2107-69-9 | 5,6-dimethoxyindan-1 -one |
| 24916-90-3 | 9-beta,11-beta-epoxy-17,21-dihydroxy-l6-alpha-methylpregna-l,4-diene-3,20-dione | |
| 2914 70 90 | 83881-08-7 | 21-chloro-9-beta, 11 -beta-epoxy-17-hydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione |
| 2915 39 90 | 979-02-2 | 20-oxopregna-5,l 6-dien-3-beta-yl acetate |
| 2915 90 20 | 638-41-5 | pentyl chloroformate |
| 2916 39 00 | 49708-81-8 | trans-4-(p-chlorophenyl)cyclohexanecarboxylic acid |
| 2917 19 90 | 48059-97-8 | (E)-oct-4-ene-1,8-dioic acid |
| 71170-82-6 | triethyl 3-bromopropane-1,1,1-tricarboxylate | |
| 2917 39 80 | 27932-00-9 | indan-5-yl hydrogen phenylmalonate |
| 2918 13 00 | 2743-38-6 | dibenzoyl-L-tartaric acid |
| 2918 17 00 | 4358-88-7 | ethyl DL-mandelate |
| 2918 19 80 | 56188-04-6 | {(1 R,3R,5S)-3,5-dihydroxy-2-[(E)-(3S)-3-hydroxyoct-1 -enyl]cyclopentyl}acetic acid |
| 2918 29 90 | 167678-46-8 | 3-chloroformyl-o-tolyl acetate |
| 2918 30 00 | 56105-81-8 | (R)-2-(3-benzoylphenyl) propionic acid |
| 22161-86-0 | (RS)-2-(3-benzoylphenyl) propionic acid | |
| 78834-75-0 | enthyl 7-chloro-2-oxoheptanoate | |
| 1944-63-4 | 3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxooctahydro-1 H-inden-4-yl]propionic acid | |
| 39562-17-9 | methyl 2-(3-nitrobenzylidene)-3-oxobutyrate | |
| 2918 90 90 | 26159-31-9 | (RS)-2-(6-methoxy-2-naphthyl)propionic acid |
| 105560-93-8 | methyl (2R,3S)-2,3-epoxy-3-(4-methoxyphenyl) propionate | |
| 40098-26-8 | methyl 7-[(3RS)-3-hydroxy-5-oxocyclopent-1-enyl]heptanoate | |
| 2921 19 80 | 4261-68-1 | (2-chloroethyl) diisopropylamine hydrochloride |
| 2921 59 90 | 122-75-8 | N, N'-dibenzylethylenediammonium di (acetate) |
| 2922 19 00 | 126456-43-7 | (1S,2R)-1-aminoindan-2-ol |
| 68047-07-4 | 4'-[2-(dimethylamino) ethoxy]-2-phenylbutyrophenone | |
| 2922 30 00 | 784-38-3 | 2-amino-5-chloro-2'-fluorobenzophenone |
| 156732-13-7 | (S)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | |
| 2922 49 70 | 37441-29-5 | 5-amino-2,4,6-triiodoisophthaloyl dichloride |
| 42854-62-6 | benzyl L-alaninate--p-toluenesulfonic acid (1:1) | |
| 39878-87-0 | (-)-alpha-(chloroformyl) benzylammonium chloride | |
| 54527-73-0 | 2-(N-methylbenzylamino) ethyl 3-aminobut-2-enoate | |
| 81677-60-3 | methyl (4-nitrophenyl)-L-alaninate | |
| 949-99-5 | 3-(4-nitrophenyl)-L-alanine | |
| 2924 10 00 | 153758-31-7 | (2S)-2-amino-3-hydroxy-N-pentylpropionamide--oxalic acid (1:1) |
| 138531-07-4 | L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-o L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysine | |
| 2924 29 90 | 40188-45-2 | 3'-acetyl-4'-hydroxybutyranilide |
| 1149-26-4 | N-(benzyloxycarbonyl)-L-valine | |
| 116661-86-0 | (2S,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-4-phenylbutyric acid | |
| 144163-85-9 | tert-butyl [(1S,3S,4S)-4-amino-1-benzyl-3-hydroxy-5-phenylpentyl] carbamate | |
| 149451-80-9 | tert-butyl [(1S,2S)-1-benzyl-2,3-dihydroxypropyl] carbamate | |
| 98737-29-2 | tert-butyl {(S)-alpha-[(S)-oxiranyl]phenethyl}carbamate | |
| 0-00-0 | 2-chloro-N-[2-(2-chlorobenzoyl)-4-nitrophenyl] acetamide | |
| 125971-96-2 | 2-[alpha-(4-fluorobenzoyl)benzyl]-4-methyl-3-oxovaleranilide | |
| 32981-85-4 | methyl (2R,3S)-3-benzamido-2-hydroxy-3-phenylpropionate | |
| 2925 19 80 | 151860-15-0 | meso-N-benzyl-3-nitrocyclopropane-1,2-dicarboximide |
| 97338-03-9 | ethyl (S)-3-(4-aminopheynl)-2-phthalimidopropionate hydrochloride | |
| 94213-26-0 | ethyl (S)-3-{4-[bis(2-chloroethyl)amino]phenyl}-2-phthalimidopropionate hydrochloride | |
| 2926 90 80 | 58311-73-2 | (Z)-(2-cyanovinyl)trimethylammonium p-toluenesulfonate |
| 133481-10-4 | ethyl (l-cyanocyclohexl)acetate | |
| 123632-23-5 | 4-(2,2,3,3-tetrafluoropropoxy)cinnamonitrile | |
| 2928 00 90 | 94213-23-7 | (Z)-[cyano(2,3-dichlorophenyl)methylene]carbazamidine |
| 2930 90 16 | 159453-24-4 | N-(benzyloxycarbonyl)-S-phenyl-L-cysteine |
| 2930 90 70 | 159878-02-1 | benzyl (1 R,2S)-3-chloro-2-hydroxy-1 -(phenylthiomethyl)propylcarbamate |
| 136511-43-8 | ethyl N-{2-[(acetylthio)methyl]-3-(o-tolyl)-1-oxopropyl}-L-methionate | |
| 2932 19 00 | 97148-39-5 | ammonium (Z)-2-methoxyimino-2-(2-furyl)acetate |
| 2932 29 80 | 517-23-7 | alpha-acetyl-gamma-butyrolactone |
| 6559-91-7 | 4'-demethylepipodophyllotoxin | |
| 39521-49-8 | (3aR,4bS,4R,4aS,5aS)-4-(5,5-dimethyl-1,3-dioxolan-2-yl)hexahydrocyclopropa[3,4]cyclopenta[l,2-b]furan-o 2(3H)-one | |
| 39746-01-5 | (3aR,4R,5R,6aS)-4-formyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate | |
| 976-70-5 | 3-oxopregn-4-ene-21,17-alpha-carbolactone | |
| 2932 99 50 | 32981-86-5 | 10-deacetylbaccatin III |
| 2932 99 70 | 7512-17-6 | 2-acetamido-2-deoxy-beta-D-glucopyranose |
| 79944-37-9 | trans-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol | |
| 125971-94-0 | tert-butyl [(4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]acetate | |
| 467-55-0 | 3-beta-hydroxy-5-alpha-spirostan-12-one | |
| 533-31-3 | 3,4-(methylenedioxy)phenol | |
| 2933 11 90 | 6150-97-6 | magnesium bis [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1 H-pyrazol-4-yl)methylamino]methane- sulfonate |
| 2933 19 90 | 27511-79-1 | 3-aminopyrazole-4-carboxamide hemisulfate |
| 2933 29 90 | 4897-25-0 | 5-chloro-1-methyl-4-nitroimidazole |
| 2933 39 95 | 142057-79-2 | (RS)-2[(1 -benzyl-4-piperidyl)methyl]-5,6-dimethoxyindan-l -one |
| 120014-07-5 | 2-[(l-benzyl-4-piperidyl)methylene]-5,6-dimethoxyindan-1-one | |
| 6935-27-9 | benzyl(2-pyridy l)amine | |
| 87848-95-1 | 6-bromo-2-pyridyl-p-tolyl ketone | |
| 32998-95-1 | N-(tert-butyl)-3-methylpyridine-2-carboxamide | |
| 84449-80-9 | 1-[2-(4-carboxyphenoxy)ethyl]piperidinium chloride | |
| 83949-32-0 | 4-carboxy-4-phenylpiperidinium p-toluenesulfonate | |
| 38092-89-6 | 8-chloro-6,11-dihydro-11-(l-methyl-4-piperidylidene)-5H-benzo[5,6]cyclohepta[l,2-b]pyridine | |
| 31255-57-9 | 3-[2-(3-chlorophenyl)ethyl]pyridine-2-carbonitrile | |
| 107256-31-5 | 3-[2-(3-chlorophenyl)ethyl]-2-pyridyl 1 -methyl-4-piperidyl ketone hydrochloride | |
| 6298-19-7 | 2-chloro-3-pyridylamine | |
| 5424-11-3 | 2,2-diphenyl-4-piperidinovaleronitrile | |
| 108555-25-5 | 1-[2-(4-methoxyphenyl)ethyl]-4-piperidylamine dihydrochloride | |
| 4046-24-6 | 5-(l -methyl-4-piperidyl)-5H-dibenzo[a,d]cyclohepten-5-ol hydrochloride | |
| 139886-04-7 | 1-methyl-1,2,5,6-tetrahydropyridine-3-carbaldehyde (E)-O-methyloxime hydrochloride | |
| 70708-28-0 | 1-(2-pyridyl)-3-(pyrrolidin-1-yl)-1-(p-tolyl)propan-1-ol | |
| 1619-34-7 | quinuclidin-3-ol | |
| 2933 40 10 | 105956-96-5 | 7-[3-(tert-butoxycarbonylamino)pyrrolidin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroc quinoline-3-carboxylic acid |
| 86393-33-1 | 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | |
| 112811-72-0 | 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | |
| 98349-25-8 | ethyl 1 -cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate | |
| 2933 40 90 | 159878-04-3 | benzyl (1S,2S)-3-[3S,4aS,8aS)-3-tert-butylcarbamoylperhydro-2-isoquinolyl]-2-hydroxy-1-(phenylthioc methyl)propylcarbamate |
| 159989-64-7 | (3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl] perhydroisoquinoline-3-carboxamide | |
| 159989-65-8 | (3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl] perhydroisoquinoline-3-carboxamide—methanesulfonic acid (1:1) | |
| 120578-03-2 | 3-[(E)-2-(7-chloro-2-quinolyl)vinyl]benzaldehyde | |
| 1087-69-0 | (9S,13S,14S)-3-methoxymorphinan hydrochloride | |
| 64228-78-0 | pentamethylene bis {3-[10-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl] propionate]- -oxalic acid (1:2) | |
| 2933 59 70 | 75128-73-3 | 2-[(2-acetamido-6-oxo-6,9-dihydro-1H-purin-9-yl)methoxy]ethyl acetate |
| 3056-33-5 | N-(9-acetyl-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide | |
| 10310-21-1 | 2-amino-6-chloropurine | |
| 124832-31-1 | 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-(benzyloxycarbonyl)-L-valinate | |
| 150378-17-9 | (2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-(3-pyridylmethyl)piperazin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxyindan-1-yl]valeramide | |
| 157810-81-6 | (2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-(3-pyridylmethyl)piperazin-1-yl]-4-hydroxy-N-[(lS,2R)-c 2-hydroxyindan-1-yl]valeramide sulfate | |
| 150323-35-6 | (3S)-1-(tert-butoxycarbonyl)-3-(tert-butylcarbamoyl)piperazine | |
| 41202-32-8 | 1-(2-chlorophenyl)piperazine hydrochloride | |
| 13078-15-4 | 1-(3-chlorophenyl)piperazine hydrochloride | |
| 71-30-7 | cytosine | |
| 149062-75-9 | 1,3-dichloro-6,7,8,9,1 0,1 2-hexahydroazepino[2,1 -b]quinazoline hydrochloride | |
| 41202-77-1 | 1-(2,3-dichlorophenyl)piperazine hydrochloride | |
| 56177-80-1 | 2-ethoxy-5-fluoropyrimidin-4(1 H)-one | |
| 112733-45-6 | ethyl (7-chloro-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-l -yl)acetate | |
| 59703-00-3 | 4-ethyl-2,3-dioxopiperazine-l-carbonyl chloride | |
| 64090-19-3 | 1-(4-fluorophenyl)piperazine dihydrochloride | |
| 147539-21-7 | isopropyl[2-(piperazin-1-yl)-3-pyridyl]amine | |
| 35386-24-4 | 1-(2-methoxyphenyl)piperazine | |
| 5464-78-8 | 1-(2-methoxyphenyl)piperazine hydrochloride | |
| 145012-50-6 | (7RS,9aRS)-perhydropyrido[l,2-a]pyrazin-7-ylmethanol | |
| 2210-93-7 | 1-phenylpiperazinium chloride | |
| 111641-17-9 | 4-(piperazin-1-yl)-2,6-bis(pyrrolidin-1-yl)pyrimidine | |
| 68-94-0 | purin-6(1 H)-one | |
| 70849-60-4 | 1-(o-tolyl)piperazine hydrochloride | |
| 2933 69 80 | 58909-39-0 | tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione |
| 2933 79 00 | 135297-22-2 | (3S,4R)-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(lR,3S)-3-methoxy-2-oxocyclohexyl]azetidin-2-one |
| 141646-08-4 | 1-|[(cyclohexyloxy)carbonyl]oxy}ethyl 1 -(1 -hydroxyethyl)-5-methoxy-2-oxo-1,2,5,6,7,8,8 a,8b-octahydroazeto*c [2,1 -a]isoindole-4-carboxylate | |
| 132127-34-5 | (3R,4S)-3-hydroxy-4-phenylazetidin-2-one | |
| 75363-99-4 | p-nitrobenzyl (2R,5R,6S)-6-[(R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate | |
| 141316-45-2 | potassium 1 -(1 -hydroxyethyl)-5-methoxy-2-oxo-1,2,5,6,7,8,8 a,8b-octahydroazeto[2,1 -a]isoindole-4-carbc oxylate | |
| 2933 90 60 | 59467-64-0 | [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methylamine |
| 59469-29-3 | [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1 H-l,4-benzodiazepin-2-ylmethyl]ammonium bis(maleate) | |
| 59467-69-5 | 8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-imidazo[l,5-a][l,4]benzodiazepine | |
| 59469-63-5 | 7-chloro-5-(2-fluorophenyl)-3-methyl-2-(nitromethylene)-2,3-dihydro-1 H-1,4-benzodiazepine 4-oxide | |
| 59467-63-9 | 7-chloro-5-(2-fluorophenyl)-2(nitromethylene)-2,3-dihydro-1 H-1,4-benzodiazepine | |
| 2933 90 95 | 130404-91-0 | N-[(R)-2-({(R)-2-[(2-adamantyloxycarbonyl)amino]-3-(lH-indol-3-yl)-2-methyl-1-oxopropyl}amino)-1- phenylethyl]succinamic acid-1-deoxy-1-methylamino-D-glucitol (1:1) |
| 122536-48-5 | 3-[(S)-3-(L-alanylamino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3- carboxylic acid hydrochloride | |
| 122536-91-8 | 7-{(S)-3-[(S)-2-(tert-butoxycarbonylamino)-1-oxopropylamino]pyrrolidin-1-yl}-1-cyclopropyl-6-fluoro-4- oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid | |
| 134575-17-0 | tert-butyl meso-3-azabicyclo[3.1.0]hex-6-ylcarbamate | |
| 122536-66-7 | tert-butyl [(S)-1-methyl-2-oxo-2-[(S)-pyrrolidin-3-ylamino]ethyl}carbamate | |
| 140629-77-2 | tert-butyl [(RS)-pyrrolidin-3-yl] carbamate | |
| 100361-18-0 | 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid | |
| 38150-27-5 | 5-chloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]ben2Ophenone | |
| 36916-19-5 | 5-chloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone | |
| 54196-62-2 | 2',5-dichloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]benzophenone | |
| 54196-61-1 | 2',5-dichloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone | |
| 141113-28-2 | (E)-( + )-2-(2,4-difluorophenyl)-1 -[3-[4-(2,2,3,3-tetrafluoropropoxy)styryl]-1 H-1,2,4-triazol-1 -yl}-3-(1 H- 1,2,4-triazol-1-yl)propan-2-ol | |
| 141113-41-9 | (R)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1 -yl)propane-1,2-diol | |
| 144034-80-0 | dimethyl{2-[5-(1 H-1,2,4-triazol-1-ylmethyl)indol-3-yl]ethyl}amine | |
| 122665-86-5 | ethyl [3-(cyanomethyl)-4-oxo-3,4-dihydrophthalazin-1 -yl]acetate | |
| 41340-36-7 | 2-(7-ethyl-lH-indol-3-yl)ethanol | |
| 95885-13-5 | 5-ethyl-4-(2-phenoxyethyl)-4H-1,2,4-triazol-3(2H)-one | |
| 96107-94-7 | ethyl 1 H-tetrazole-5-carboxylate, sodium salt | |
| 96034-57-0 | trans-4-hydroxy-1-(4-nitrobenzyloxycarbonyl)-L-proline | |
| 160194-26-3 | 2-iodo-4-(1 H-1,2,4-triazol-1-ylmethyl)aniline | |
| 66635-71-0 | isopropyl 2,3-dihydro-1 H-pyrrolizine-1-carboxylate | |
| 4928-88-5 | methyl 1 H-1,2,4-triazole-3-carboxylate | |
| 0-00-0 | 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid sulfate | |
| 112193-77-8 | 1,4,7,10-tetraazoniacyclododecane bis(sulfate) | |
| 3641-08-5 | 1 H-l,2,4-triazole-3-carboxamide | |
| 4928-87-4 | 1 H-1,2,4-triazole-3-carboxylic acid | |
| 6969-71-7 | 1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | |
| 2934 10 00 | 171485-87-3 | 2-[4-(2-amino-4-oxo-4,5-dihydrothiazol-5-ylmethyl)phenoxymethyl]-2,5,7,8-tetramethylchroman-6-yl acetate |
| 65872-41-5 | (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetic acid | |
| 64486-18-6 | (Z)-2-[2-(chloroacetamido)thiazol-4-yl]-2-(methoxyimino) acetic acid | |
| 76823-93-3 | 1-{4-[(2-cyanoethyl)thiomethyl]thiazol-2-yl}guanidine | |
| 139340-56-0 | [5-[(Z)-3,5-di(tert-butyl)-4-hydroxybenzylidene]-4-oxo-4,5-dihydrothiazol-2-yl]ammonium methanec sulfonate | |
| 64485-88-7 | ethyl (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino) acetate | |
| 66339-00-2 | ethyl 2-(hydroxyimino)-2-[2-(tritylamino)thiazol-4-yl]acetate hydrochloride | |
| 88046-01-9 | 2-guanidinothiazol-4-ylmethyl carbamimidothioate dihydrochloride | |
| 154212-61-0 | N-[2-isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine | |
| 66215-71-2 | (Z)-2-methoxyimino-2-[2-(tritylamino)thiazol-4-yl] acetic acid | |
| 154212-59-6 | 4-nitrophenyl thiazol-5-ylmethyl carbonate hydrochloride | |
| 38585-74-9 | thiazol-5-ylmethanol | |
| 155213-67-5 | thiazol-5-ylmethyl (lS,2S,4S)-1-benzyl-2-hydroxy-4-{(2S)-2-[3-(2-isopropylthiazol-4-ylmethyl)-3-methyl ureido]-3-methylbutyramido}-5-phenylpentylcarbamate | |
| 2934 20 50 | 80756-85-0 | S-(benzothiazol-2-yl) (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminothioacetate |
| 2934 20 90 | 87691-88-1 | 1-(1,2-benzisothiazol-3-yl)piperazine hydrochloride |
| 2934 90 50 | 111974-69-7 | 2-{2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy}ethanol |
| 42399-49-5 | (2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one | |
| 2934 90 60 | 115787-67-2 | 2-(2-amino-5-nitro-6-oxo-1,6-dihydropyrimidin-4-yl)-3-(3-thienyl)propiononitrile |
| 117829-20-6 | 2-amino-7-thenyl-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one hydrochloride | |
| 112887-68-0 | N-{5-[(1,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)methylamino]-2-thenoyl}-L-glutamic acid | |
| 161005-84-1 | (S)-N,N-dimethyl-[3-(2-thienyl)-3-(1-naphthyloxy)propyl]amine-phosphoric acid (1:1) | |
| 104795-66-6 | 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2-carboxamide | |
| 104795-67-7 | 3-isopropoxy-5-methoxy-N-(1H-tetrazoI-5-yl)benzo[b]thiophene-2-carboxamide-1H-imidazole (1:1) | |
| 104795-68-8 | 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2-carboxamide, sodium salt | |
| 63675-74-1 | 6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene | |
| 138564-59-7 | 5-methyl-2-(2-nitroanilino)thiophene-3-carbonitrile | |
| 2934 90 70 | 25229-97-4 | 2-cyano-3-morpholinoacrylamide |
| 2934 90 80 | 119221-49-7 | 5-[(2-aminoethyl)amino]-2-(2-diethylaminoethyl)-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol |
| 147086-81-5 | (4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol 7,7-dioxide | |
| 2934 90 98 | 58-61-7 | adenosine |
| 152305-23-2 | (S)-4-(4-aminobenzyl)oxazolidin-2-one | |
| 71420-85-4 | 7-amino-3-[1-(sulfomethyl)-1H-tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acid, sodium salt | |
| 29706-84-1 | 3'-azido-3'-deoxy-5'-0-tritylthymidine | |
| 51762-51-7 | benzhydryl 3-hydroxy-7-(phenylacetamido)cepham-4-carboxylate | |
| 110314-42-6 | 5-[(benzofuran-2-ylcarbonyl)amino]indole-2-carboxylic acid | |
| 131986-28-2 | 3-(4-chloro-1,2,5-thiadiazol-3-yl)pyridine | |
| 107452-89-1 | omega-conotoxin M VIIA | |
| 126429-09-2 | 2-(dichloromethyl)-4,5-dihydro-5-(4-mesylphenyl)oxazol-4-ylmethanol | |
| 126813-11-4 | (4R,5R)-2-(dichloromethyl)-4,5-dihydro-5-(4-mesylphenyl)oxazol-4-ylmethanol | |
| 4097-22-7 | 2',3'-dideoxyadenosine | |
| 139264-17-8 | (S)-4-{[3-(2-dimethylaminoethyl)-1H-indol-5-yI]methyl}oxazolidin-2-one | |
| 110351-94-5 | (S)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione | |
| 140841-32-3 | 6-[3-fluoro-5-(4-methoxytetrahydropyran-4-yl)phenoxymethyl]-1-methyl-2-quinolone | |
| 94732-98-6 | 1-(1-{3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl}-4-piperidyl)-2,3-dihydro-1H-benzimidazole-2-thione | |
| 125995-03-1 | (4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxy tetrahydro-2H-pyran-2-one | |
| 131988-19-7 | 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1-methylpyridinium iodide | |
| 147027-10-9 | (1R,2S,5R)-menthyl (2R,5S)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-1,3-oxathiolane-2-carboxylate | |
| 147126-62-3 | (1R,2S,5R)-menthyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate | |
| 104218-44-2 | 3'-O-mesyl-5'-O-tritylthymidine | |
| 27255-72-7 | 3-methyl-7-(phenylacetamido)-3-cephem-4-carboxylic acid | |
| 0-00-0 | (1R,2S,3S,6R)-[(S)-1-phenylethyl]-3,6-epoxytetrahydrophthalimide | |
| 32231-06-4 | 1-piperonylpiperazine | |
| 55612-11-8 | 5'-O-tritylthymidine | |
| 2935 00 90 | 151140-66-8 | (4-amino-3-iodophenyl)-N-methylmethanesulfonamide |
| 112101-81-2 | 5-[(R)-(2-aminopropyl)]-2-methoxybenzenesulfonamide | |
| 120298-38-6 | N-(5,6-dihydro-6-methyl-2-sulfamoyl-4H-thieno[2,3-b]thiopyran-4-yl)acetamide 7,7-dioxide | |
| 150975-95-4 | 5-methanesulfonamidoindole-2-carboxylic acid | |
| 84522-34-9 | sodium 4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulfonamide | |
| 2939 10 00 | 66820-84-6 | (RS)-tetrahydropapaverine hydrochloride |
| 2940 00 90 | 13035-61-5 | 1,2,3,5-tetraacetyl-beta-D-ribofuranose |
| 3824 90 64 | 330-95-0 | 1,3-bis(4-nitrophenyl)urea--4,6-dimethylpyrimidin-2-ol (1:1) |
| 104832-01-1 | (R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline~dibenzoyl-L-tartaric acid (1:1) | |
| 0-00-0 | Intermediate concentrate obtained from a genetically-modified Escherichia coli fermentation medium, containing human granulocyte-macrophage colony-stimulating factor; for use in the manufacture of medicaments of HS No 30.02 | |
| 0-00-0 | Intermediate concentrate obtained from a genetically-modified Escherichia coli fermentation medium, containing human interferon alpha-2b; for use in the manufacture of medicaments of HS No 30.02 | |
| 0-00-0 | Intermediate concentrates obtained from a Micromonospora inyoensis fermentation medium used for the manufacture of the antibiotics sisomicin (INN) and netilmicin (INN) | |
| 0-00-0 | Intermediate concentrates obtained from a Micromonospora purpurea fermentation medium used for the manufacture of the antibiotics gentamicin sulfate (INNM) and isepamicin (INN) | |
| 3824 90 95 | 0-00-0 | ethyl 7-chloro-2-oxoheptanoate, in the form of a solution in toluene |
| 3911 90 | 162430-94-6 | 1,6-hexanediamine, polymer with 1,10-dibromodecane |
| 3913 90 80 | 83513-48-8 | danaparoid sodium |
ANNEX IIIU.K.Additions to the list of prefixes and suffixes which, in combination with the INNs, describe salts, esters or hydrates of INNs
N-acetylglycinate
acistrate
acoxil
amsonate
benzathine
bezomil
buciclate
bunapsilate
buteprate
butyl ester
carbesilate
p-chlorobenzenesulfonate
p-chlorobenzenesulphonate
ciclotate
cipionate
closilate
closylate
crobefate
cromacate
cromesilate
cyclopentanepropionate
cyclotate
cypionate
dapropate
deanil
decil
dibudinate
dibunate
diethanolamine
digolil
N,N-dimethyl-beta-alanine
diolamine
docosil
dofosfate
edamine
edisylate
epolamine
erbumine
etabonate
ethanolamine
ethylenediamine
farnesil
fendizoate
fostedate
hibenzate
hybenzate
hyclate
o-(4-hydroxybenzoyl)benzoate
isocaproate
lauril
laurilsulfate
laurilsulphate
lauryl
laurylsulfate
laurylsulphate
megallate
metembonate
4-methylbicyclo[2.2.2]oct-2-ene-l-carboxylate
mofetil
octil
olamine
oxoglurate
pendetide
pivoxetil
proxetil
l-pyrrolidineethanol
sodium lauril sulfate
sodium lauril sulphate
sodium lauryl sulfate
sodium lauryl sulphate
steaglate
tenoate
teprosilate
tetradecyl hydrogen phosphate
tofesilate
triclofenate
triethanolamine
triflutate
trolamine
trometamol
tromethamine
troxundate
xinafoate
ANNEX IVU.K.INNs which shall no longer benefit from duty-free treatment
| CN code | CAS RN | Name |
|---|---|---|
| 2903 22 00 | 79-01-6 | trichloroethylene |
| 2903 30 10 | 811-97-2 | norflurane |
| 2903 51 10 | 58-89-9 | lindane |
| 2906 21 00 | 100-51-6 | benzyl alcohol |
| 2915 29 00 | 82279-57-0 | zinc acetate, basic |
| 2922 41 00 | 56-87-1 | lysine |
| 2922 42 90 | 56-86-0 | glutamic acid |
| 2922 49 10 | 56-40-6 | glycine |
| 2922 50 00 | 72-19-5 | threonine |
| 2923 10 10 | 67-48-1 | choline chloride |
| 2928 00 90 | 79-17-4 | pimagedine |
| 2930 90 20 | 111-48-8 | thiodiglycol |
| 2933 90 95 | 73-22-3 | tryptophan |
| 3102 70 10 | 156-62-7 | calcium carbimide |
| 3904 61 10 | 9002-84-0 | politef |
| 3906 90 90 | 54182-57-9 | carbomer |
| 3907 20 | 0-00-0 | macrogol ester |
| 3907 20 12 | 25322-68-3 | macrogol |
| 3907 20 21 | 25301-02-4 | tyloxapol |
| 3907 60 10 | 25038-59-9 | pegoterate |
| 3908 10 00 | 25038-54-4 | policapram |
| 3910 00 00 | 9006-65-9 | dimeticone |
| 3912 20 11 | 9004-70-0 | pyroxylin |
| 3912 31 00 | 9000-11-7 | carmellose |
| 3912 39 80 | 8063-82-9 | hypromellose |
Options/Help
Print Options
PrintThe Whole Regulation
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the EU Official Journal
- lists of changes made by and/or affecting this legislation item
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.